Learning that our own cells can regenerate damaged heart tissue – when processed properly – even after catastrophic trauma gave me a whole new perspective to medicine and understood that Stem cell therapy was the future of medicine, I was suddenly very aware of our own mortality but in SCT saw the fountain of youth staring right back at me.
I travelled to Thailand where I met Dr. Porat, and, guided and mentored by her, I immersed myself in factual data backed by academic institutions and researching SCT progress outside the US. At that time, the Bush administration had banned Stem Cell Research in the US, giving in to large Pharma company’s interest, creating negative propaganda and resulting in a 10 year American setback in research and development at the expense of no-option patients in desperate need of this new technology. Since then, I have dedicated all my time and resources in finding, evaluating and nurturing medical and scientific talent, focusing exclusively on autologous processed cells (from your own body).
I formed Rejuvenare in 2008 and since then, our commitment and vision has remained the same; “to continue providing research and development to the highest standards within safety and efficacy in therapies validated by academic institutions, providing consistent results in therapies to treat progressive life altering diseases, giving hope to the hopeless and no-option patients whom are willing to consider alternative options.”
I have been blessed to cross paths with, now one of my best friends, Dr. Yael Porat, PhD, in this formidable quest to help humanity, and together, we share with our team and colleagues the highest ethic standards and honest caring compassionate principles.
Stem Cell Therapy (SCT) is NOT yet a cure for disease but it may significantly improve the quality of life of those who qualify and are invited for treatment.
The FDA does not regulate SCT so it is not offered within the United States. Clinical trials are being held to FDA specifications but, because such clinical trials are time sensitive and very expensive, it will probably take another 15 years for SCT to be available to treat some diseases inside the USA.
There are only a handful of reputable clinics performing safe SCT offshore offering consistency, safety and efficacy with real scientific study behind them.
Over the years, funding for Rejuvenare was extremely hard to secure since, to us, it was of the utmost importance to find the right humanitarian and ethical approach we collectively share as a team. We were never going to compromise our core values and principles to monetary interest. Now, we have just secured strategic partnerships with various academic institutions and are very excited for new cell lines we have developed and expect to soon start human clinical trials to address fascinating challenges such as addiction, Alzheimer’s, MS and perhaps imporve our already successful therapies for Parkinson’s, early dementia and stroke.